CZ148695A3 - Antacid composition and process for preparing thereof - Google Patents

Antacid composition and process for preparing thereof Download PDF

Info

Publication number
CZ148695A3
CZ148695A3 CZ951486A CZ148695A CZ148695A3 CZ 148695 A3 CZ148695 A3 CZ 148695A3 CZ 951486 A CZ951486 A CZ 951486A CZ 148695 A CZ148695 A CZ 148695A CZ 148695 A3 CZ148695 A3 CZ 148695A3
Authority
CZ
Czechia
Prior art keywords
particles
aluminum
antacid
neutralizing agent
antacid composition
Prior art date
Application number
CZ951486A
Other languages
Czech (cs)
English (en)
Inventor
Gary G Liversidge
Gregory L Mcintire
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of CZ148695A3 publication Critical patent/CZ148695A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CZ951486A 1992-12-11 1993-12-03 Antacid composition and process for preparing thereof CZ148695A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11

Publications (1)

Publication Number Publication Date
CZ148695A3 true CZ148695A3 (en) 1995-12-13

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ951486A CZ148695A3 (en) 1992-12-11 1993-12-03 Antacid composition and process for preparing thereof

Country Status (10)

Country Link
EP (1) EP0673253A1 (fi)
JP (1) JPH08504442A (fi)
KR (1) KR950703982A (fi)
AU (1) AU6390894A (fi)
CA (1) CA2150383A1 (fi)
CZ (1) CZ148695A3 (fi)
FI (1) FI952859A (fi)
NO (1) NO952261D0 (fi)
SK (1) SK76595A3 (fi)
WO (1) WO1994013304A2 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413544T2 (de) * 1993-08-24 1999-05-27 Kappa Pharmaceuticals Ltd., Reading Reduzierte absorption von fettsäuren
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
WO2016104367A1 (ja) * 2014-12-22 2016-06-30 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
WO1994013304A3 (en) 1994-09-01
EP0673253A1 (en) 1995-09-27
JPH08504442A (ja) 1996-05-14
CA2150383A1 (en) 1994-06-23
FI952859A0 (fi) 1995-06-09
KR950703982A (ko) 1995-11-17
NO952261L (no) 1995-06-08
AU6390894A (en) 1994-07-04
WO1994013304A2 (en) 1994-06-23
SK76595A3 (en) 1997-01-08
FI952859A (fi) 1995-06-09
NO952261D0 (no) 1995-06-08

Similar Documents

Publication Publication Date Title
RU2186562C2 (ru) Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
JP4709873B2 (ja) ナノ粒子組成物
JP2022010290A (ja) 粘液浸透性被覆粒子、組成物、医薬組成物、医薬製剤、及びそれらの形成方法
JP5923065B2 (ja) 過酸化物及びレチノイドを含む局所適用用組成物
Dolenc et al. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition
CN1870980B (zh) 控释无菌阿立哌唑注射剂和方法
HUT65758A (en) Nanogranules containing surface modifier and cloud point modifier and process for production of them
HU228097B1 (en) Pharmaceutical nanosuspension for medicament administration as systems with increased saturation solubility and speed of dissolution
CZ253893A3 (en) Agent containing nano-particles and process for preparing nano-particles
NO303668B1 (no) Overflatemodifiserte legemiddel-nanopartikler, fremgangsmÕte for deres fremstilling samt dispersjon inneholdende slike partikler
JPH06211647A (ja) ナノ粒子を含む組成物及びその製造方法
CA2206430A1 (en) Sugar base surfactant for nanocrystals
CN109331184A (zh) 一种荷正电药物纳米结晶制剂及其制备方法
WO2007144362A1 (en) A suspension comprising benzimidazole carbamate and a polysorbate
CZ148695A3 (en) Antacid composition and process for preparing thereof
EP1658052B1 (en) Particle size reduction of bioactive compounds
Im-Emsap et al. Disperse systems
Lheritier et al. Improvement of the dissolution kinetics of SR 33557 by means of solid dispersions containing PEG 6000
Hadke et al. Formulation development and characterization of lyophilized febuxostat nanosuspension
HUT72052A (en) Antacid compositions and methods of production
US20230310442A1 (en) Poly hydroxy oligomer coated dolutegravir aquasomes and method thereof
Santhosh et al. An Overview of Preparation, Characterization, and Application of Aquasomes
Magi et al. Organic solvent-free Benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease
US20220000784A1 (en) Spherical beads for use in producing pharmaceutically active pellets
Challa et al. FORMULATION AND EVALUATION OF STABLE NANOSUSPENSION OF SELECTIVE POOR LY SOLUBLE DRUG RITONAVIR